Menu
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Amgen Inc. sell Robert W. Baird

Start price
€282.70
25.09.24 / 50%
Target price
€192.49
25.09.25
Performance (%)
-17.35%
End price
€233.65
26.09.25
Summary
This prediction ended on 26.09.25 with a price of €233.65. The prediction for Amgen Inc. closed with a convincing performance of -17.35%. Robert_W__Baird has a follow-up prediction for Amgen Inc. where he still thinks Amgen Inc. is a Sell. Dividends of €9.15 are taken into consideration when calculating the performance. Robert_W__Baird has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Amgen Inc. 0.999% 0.999% 44.041%
iShares Core DAX® 0,44 % 5,64 % 7,81 %
iShares Nasdaq 100 1,06 % 0,28 % 27,24 %
iShares Nikkei 225® 1,77 % 0,41 % 49,27 %
iShares S&P 500 0,37 % 1,92 % 22,34 %

Comments by Robert_W__Baird for this prediction

In the thread Amgen Inc. diskutieren
Prediction Sell
Perf. (%) -17.35%
Target price 192.490
Change
Ends at 25.09.25

Amgen Inc. (NASDAQ: AMGN) had its "underperform" rating re-affirmed by analysts at Robert W. Baird. They now have a $215.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat

In the thread Trading Amgen Inc.
Prediction Sell
Perf. (%) -17.35%
Target price 192.490
Change
Ends at 25.09.25

Die von Robert_W__Baird gewählte maximale Laufzeit wurde überschritten

Current prediction by Robert_W__Baird for Amgen Inc.

Amgen Inc.

Start price
Target price
Perf. (%)
€337.30
05.08.26
€199.36
05.08.27
6.42%
14.08.26